Wednesday, October 24, 2012

Novartis flu vaccines

  • Italy Bans Novartis Flu Vaccines, Citing Side Effects

    Italy and Switzerland halted sales of Novartis AG's (NOVN) flu vaccines after the company informed Italian authorities of a buildup of particles in the shots.

    www.businessweek.com

  • Novartis Banks on Meningitis Shot to Justify 'Oops' Deal

    The performance at Novartis's vaccines and diagnostics division has been another story. Sales peaked at $2.9 billion in 2010 on revenue from influenza vaccines sold during the H1N1 flu pandemic. Last year the business had revenue of $2 billion and a ...

    www.businessweek.com

  • University of Minnesota researchers call for better flu vaccine

    Currently, 6 companies are licensed to produce and distribute flu vaccines in the U.S.: CSL, GlaxoSmithKline ($GSK), ID Biomedical, AstraZeneca's ($AZN) MedImmune, Novartis ($NVS) and Sanofi Pasteur. This year, a total of 135 million doses of influenza ...

    www.fiercevaccines.com

  • Flu vaccine manufacturers face steep odds

    This year's dose includes one strain in common with last year's and two new ones. But judging by vaccination rates from the previous flu season, the manufacturers--CSL, GlaxosmithKline ($GSK), ID Biomedical, AstraZeneca's ($AZN) MedImmune, Novartis ...

    www.fiercevaccines.com

  • Mix-up over vaccines upsets Berks seniors

    Doctors and other flu vaccine providers began getting phone calls after Oct. 1 from seniors who said the routine explanation of benefits they receive after getting a treatment or therapy through Medicare listed the shot they thought was their seasonal ...

    readingeagle.com

  • OMG! Flu Cases Reported in Michigan.

    Michigan Department of Community Health Director James Haveman said in a statement Monday that the flu vaccine is the "single best way" to protect against the illness.

    www.lewrockwell.com

  • Anti-virus software: Genomics firm using 3D printers to create vaccines ...

    In 2010 it signed an agreement with Novartis to use synthetic genomics tools and technologies to speed up the production of the influenza seed strains needed for vaccine manufacturing, according to its website. It is also working on taking DNA from one ...

    medcitynews.com

  • Inovio Pharmaceuticals sees two candidates in FierceVaccines' top 10 ...

    The company has clinical programs for cervical dysplasia, leukemia, the hep C virus, the flu and HIV. For many years, vaccines were associated with the prevention of infectious diseases, but ... Other notable candidates on the FierceVaccine list ...

    www.proactiveinvestors.com

  • Influenza Vaccine Market - Global Industry Analysis, Market Size, Share ...

    Seasonal influenza vaccine brands like Fluarix & Flulaval were one of the leading players in the market in 2010. Other key players in this market include GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun ...

    www.sbwire.com

  • 3 Things to Watch With Dynavax

    The company is currently in phase 1 trials with a universal flu vaccine. Novartis (NYS: NVS) partners as a supplier for a key component to this vaccine.

    www.dailyfinance.com

  • 20 Top-selling Vaccines -- H1 2012

    Thanks in part to the adult influenza market and vaccines such as Gardasil and Prevnar, the global vaccines market has enjoyed a decidedly solid boost in revenue.

    www.fiercevaccines.com

  • Protein Technologies' reactive labels alert medical staff

    He said: "In 2006, when a shipment of almost 20,000 flu vaccines was mistakenly frozen, the pharmaceutical company, Novartis, elected to destroy the entire batch of 500,000 doses rather than risk the chance of a single patient suffering an immunogenic ...

    menmedia.co.uk

No comments:

Post a Comment